Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01521741 · ClinicalTrials.gov registry record
Prospective Screening for Breast Cancer-related Lymphedema
A clinical trial of Lymphedema, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT01521741 is a study of Lymphedema that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 10,000 participants, above the 9,006-participant average among 34 other Lymphedema trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01521741, a study of Lymphedema, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objectives of this study are twofold: 1) to detect and determine the level of symptoms, functional disability, and changes in quality of life that breast cancer patients experience from changes in their arms during and after treatment for breast cancer by collecting patient reported outcome measures, objective measurements, and clinical information in a prospectively maintained database and 2) to improve breast cancer-related lymphedema outcomes by early detection using objective measurements and symptoms assessments and assess these outcomes by maintaining the data in a database in order to contribute to the literature. The secondary aim of this study is to assess extracellular fluid content in the upper extremity, breast, and/or trunk of patients treated for breast cancer before, during, and after treatment in order to better understand the role of bioimpedance spectroscopy in lymphedema screening.
Conditions Studied
Interventions
- OTHER Breast Cancer-Related Lymphedema Screening
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2009-08 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01521741
The ClinicalTrials.gov registry entry for NCT01521741 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 9,006-participant average among 34 other Lymphedema trials with a reported enrollment target (11% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lymphedema appearing as the primary indexed condition, and to 1 intervention - of which Breast Cancer-Related Lymphedema Screening is the first listed.
NCT01521741 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01521741 about?
NCT01521741 is a clinical study titled "Prospective Screening for Breast Cancer-related Lymphedema". The primary objectives of this study are twofold: 1) to detect and determine the level of symptoms, functional disability, and changes in quality of life that breast cancer patients experience from changes in their arms during and after treatment for breast cancer by collecting patient reported outc...
What is the current status of trial NCT01521741?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2009-08. Estimated completion is 2026-12.
What conditions does trial NCT01521741 study?
This clinical trial studies the following conditions: Lymphedema.
What interventions are being tested in trial NCT01521741?
The interventions under investigation include: Breast Cancer-Related Lymphedema Screening (OTHER).
Who is sponsoring clinical trial NCT01521741?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01521741 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lymphedema Surveillance Study
RECRUITING
-
Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema
RECRUITING · Early Phase 1
-
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
RECRUITING · Phase 2
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
RECRUITING · Phase 3
-
Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.